Dako Scientist Says Most Cancer Meds Will Be Dx-Based, Personalized in Next Decade

Since many cancer patients today routinely have tumor samples biopsied and analyzed to help better target treatments, “it is expected that in 10-15 years very few [cancer] drugs will be prescribed without such a test.”

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.